PHILADELPHIA and BALTIMORE, Nov. 09, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocyte (MILs®) products for cancer immunotherapy, today ...
Protecting multiple levels of sensitive data on U.S. military aircraft today requires duplicative hardware–a costly and inefficient solution. We describe an alternative approach, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results